Publications

(2023). A transient positive association between direct-acting antiviral therapy for hepatitis C infection and drug-related hospitalization among people who inject drugs: Self-controlled case-series analysis of national data. Addiction.

DOI

(2023). National increase in the community supply of take-home naloxone associated with a mass media campaign in Scotland: a segmented time series analysis. International Journal of Drug Policy.

DOI

(2023). Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study. BMJ.

DOI

(2023). Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011-20: a national retrospective cohort study. Lancet Public Health.

DOI

(2022). Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?. American Journal of Gastroenterology.

DOI

(2022). Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study. Drug and Alcohol Dependence.

DOI

(2021). Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort study. Liver International.

DOI

(2021). Competing risk bias in prognostic models predicting hepatocellular carcinoma occurrence: impact on clinical decision making. Gastro Hep Advances.

DOI

(2021). Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs. Journal of Hepatology.

DOI

(2021). Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured hepatitis C infection. JHEP Reports.

DOI

(2021). A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage. International Journal of Drug Policy.

DOI

(2021). Reduction in the population prevalence of HCV viraemia among people who inject drugs associated with scale-up of direct-acting antiviral therapy in community drug services: real world data. Addiction.

DOI

(2021). Implementation of a national HIV pre-exposure prophylaxis service is associated with changes in characteristics of people with newly diagnosed HIV: a retrospective cohort study. Sexually Transmitted Infections.

DOI

(2020). Population-level effectiveness of a national HIV pre-exposure prophylaxis programme in MSM. AIDS.

DOI

(2020). Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study. Gut (BMJ).

DOI

(2019). Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol). BMJ Open.

PDF DOI

(2019). Emergence of Novel Psychoactive Substance injecting associated with rapid rise in the population prevalence of hepatitis C virus. International Journal of Drug Policy.

DOI

(2019). Implementation of HIV PrEP in Scotland: First Year Report. Health Protection Scotland.

PDF Project

(2017). Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs. Addiction.

DOI

(2017). Assessing the impact of a temporary class drug order on ethylphenidate-related infections among people who inject drugs in Lothian, Scotland: an interrupted time-series analysis. Addiction.

PDF Slides DOI

(2017). Hepatitis B infection in Scotland: 2015. Health Protection Scotland.

PDF Project

(2016). Statistical Applications in the Analysis of Vaccine Preventable Diseases. University of Strathclyde.

PDF Project